A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects
NCT03593278
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
ACT-246475
Sponsor
Viatris Innovation GmbH